Matsui Ryota, Inaki Noriyuki, Tsuji Toshikatsu
Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Department of Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan.
Surg Today. 2022 Sep;52(9):1382-1391. doi: 10.1007/s00595-022-02482-y. Epub 2022 Feb 28.
We investigated the long-term prognostic impact of diabetes mellitus (DM) after gastrectomy for advanced gastric cancer.
This was a retrospective cohort study of consecutive patients who underwent gastrectomy for primary p-T2 or more advanced-stage gastric cancer, between April, 2008 and June, 2018. The overall survival (OS) of patients with DM and those without DM were compared using Kaplan-Meier survival analysis after adjusting for group differences using propensity score matching (PSM).
Among the 512 patients who met the eligibility criteria, 92 (18.0%) had DM and 420 (82.0%) did not. After PSM, the subjects of this analysis were 72 patients in the DM group and 216 patients in the non-DM. OS was significantly worse in the DM group than in the non-DM group (P = 0.037). Multivariate analysis revealed that a low skeletal muscle mass index was a significant independent prognostic factor for OS in the patients with DM (hazard ratio, 2.284; 95% confidence interval, 1.005-5.189; P = 0.048).
DM in patients with advanced gastric cancer is associated with poor OS. A low skeletal muscle mass in patients with DM is a particularly poor prognostic factor for OS after surgery for gastric cancer.
我们研究了晚期胃癌胃切除术后糖尿病(DM)的长期预后影响。
这是一项回顾性队列研究,研究对象为2008年4月至2018年6月期间因原发性p - T2期或更晚期胃癌接受胃切除术的连续患者。使用倾向评分匹配(PSM)调整组间差异后,采用Kaplan - Meier生存分析比较糖尿病患者和非糖尿病患者的总生存期(OS)。
在符合纳入标准的512例患者中,92例(18.0%)患有糖尿病,420例(82.0%)未患糖尿病。PSM后,本分析的对象为糖尿病组72例患者和非糖尿病组216例患者。糖尿病组的总生存期显著低于非糖尿病组(P = 0.037)。多因素分析显示,低骨骼肌质量指数是糖尿病患者总生存期的显著独立预后因素(风险比,2.284;95%置信区间,1.005 - 5.189;P = 0.048)。
晚期胃癌患者的糖尿病与不良总生存期相关。糖尿病患者的低骨骼肌质量是胃癌手术后总生存期特别差的预后因素。